BRIEF-Cerulean Pharma reports Q3 2016 financial results

* Announced reduction in force of approximately 48% percent, which company expects to be substantially completed by end of 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.